Syndrome malin des neuroleptiques à la palipéridone palmitate (notice n° 681559)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02602cam a2200337 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121203329.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Saadi, Ikram |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Syndrome malin des neuroleptiques à la palipéridone palmitate |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 23 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Le syndrome malin des neuroleptiques est un effet indésirable des psychotropes, rare mais grave. L’incidence de ce syndrome varie entre 0,07 et 2,2 % selon les études. L’évolution mortelle qui y est liée est estimée à 30 %. À la lumière d’une vignette clinique et d’une revue de littérature récente, nous présentons ici un cas clinique de syndrome malin atypique, de par la molécule incriminée qui est la palipéridone palmitate, sa chronologie d’apparition retardée, ainsi que sa présentation. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Neuroleptic malignant syndrome (NMS) is a rare but serious adverse reaction to antipsychotic drugs. According to studies, the incidence of this syndrome varies between 0.07 and 2.2 percent. The risk of fatal outcome associated with NMS is estimated at 30 percent. Based on a clinical vignette and a recent literature review, in this paper we present a clinical case of atypical malignant syndrome caused by the incriminated molecule paliperidone palmitate, as well as its delayed onset, and its presentation. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | El síndrome neuroléptico maligno (SNM) es un efecto adverso de los psicofármacos, poco frecuente pero grave. La incidencia de este síndrome varía entre el 0,07 y el 2,2% según los estudios. El desenlace fatal relacionado con él se estima en un 30%. A la luz de una viñeta clínica y de una repaso reciente de la literatura, presentamos aquí un caso clínico de síndrome maligno atípico, debido a la molécula incriminada que es el palmitato de paliperidona, su cronología de inicio retardado, así como su presentación. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | revue de la littérature |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cas clinique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | traitement retard |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | syndrome malin des neuroleptiques |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | neuroleptique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | clinical case |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | literature review |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | neuroleptic malignant syndrome |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | neuroleptic |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | delayed treatment |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Imounachen, Bouchra |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Oneib, Bouchra |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Reca, Martin |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | L'information psychiatrique | Volume 99 | 3 | 2023-04-05 | p. 169-172 | 0020-0204 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-l-information-psychiatrique-2023-3-page-169?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-l-information-psychiatrique-2023-3-page-169?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux